[1]
Dolatkhah, R., Jam, E.I., Nikanfar, A., Esfahani, A., Chavooshi, S.H., Nejati, B. and Sanaat, Z. 2019. Outcome analysis of acute myeloid leukemia patients treated with high dose daunorubicin. Biomedical Research and Therapy. 6, 9 (Sep. 2019), 3347-3351. DOI:https://doi.org/10.15419/bmrat.v6i9.562.